Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

An antimicrobial peptide of the cathelicidin family that provides innate immune defense by killing pathogens and modulating inflammation and wound healing.

Quick Stats
Studies 2230
Trials 95
Formula C205H340N60O53
Clear All
Utility 1
pubmed May 31, 2013

Pretherapeutic plasma pro- and anti- inflammatory mediators are related to high risk of oral mucositis in pediatric patients with acute leukemia: a prospective cohort study.

Ye. Ying Y; Carlsson. Göran G; Agholme. Monica Barr MB; Karlsson-Sjöberg. Jenny J; Yucel-L...

In kids with acute leukemia, higher levels of inflammatory molecules and lower levels of the antimicrobial protein pro‑LL‑37 in the blood before treatment were linked to a greater chance of getting painful mouth sores (oral mucositis) during chemotherapy.

Utility 1
pubmed Dec 1, 2012

Vascular endothelial growth factor production is induced by histone deacetylase 1 and suppressed by von Hippel-Lindau protein in HaCaT cells.

Reynoso-Roldán. Angélica A; Roldán. Maria L ML; Cancino-Diaz. Juan C JC; Rodrígu...

In skin cells grown in the lab, the peptide LL‑37 and a protein called HDAC1 boost the production of VEGF, a factor that promotes new blood vessel growth, while another protein, VHL, reduces VEGF levels. These changes happen through the HIF‑1α pathway, which controls how cells respond to low oxygen.

Utility 1
pubmed 2013

Expression of antimicrobial peptides in atopic dermatitis and possible immunoregulatory functions.

Kopfnagel. Verena V; Harder. Jürgen J; Werfel. Thomas T

LL-37 and other antimicrobial peptides are found in the skin of people with atopic dermatitis, but they are usually lower than in psoriasis. These peptides can both fight microbes and stir up inflammation, and the allergic‑type signals (Th2 cytokines) in atopic dermatitis can suppress their production, meaning they might not be enough to keep the skin clean.

Utility 1
pubmed Dec 19, 2011

Innate immunity against Granulibacter bethesdensis, an emerging gram-negative bacterial pathogen.

Zarember. Kol A KA; Marshall-Batty. Kimberly R KR; Cruz. Anna R AR; Chu. Jessica J; Fenster. Michael...

The study shows that the human antimicrobial peptide LL‑37 does not kill the bacteria Granulibacter bethesdensis, which can cause infections in people with immune deficiencies. This pathogen can survive in blood and avoids being killed by immune cells, especially in those lacking proper oxidative killing mechanisms.

Utility 1
pubmed Apr 3, 2013

Antimicrobial peptides and proinflammatory cytokines in periprosthetic joint infection.

Gollwitzer. Hans H; Dombrowski. Yvonne Y; Prodinger. Peter M PM; Peric. Mark M; Summer. Burkhard B;...

Researchers measured the antimicrobial peptide LL-37 (and a few others) in joint fluid and blood to see if it could help tell the difference between infected and non‑infected joint replacements. They found LL-37 was higher in the joint fluid of infected patients and, when combined with certain cytokines, gave fairly good diagnostic accuracy. Blood levels didn’t show the same clear pattern.

Utility 1
pubmed Mar 1, 2011

Human anti-microbial cathelicidin peptide LL-37 suppresses the LPS-induced apoptosis of endothelial cells.

Suzuki. Kaori K; Murakami. Taisuke T; Kuwahara-Arai. Kyoko K; Tamura. Hiroshi H; Hiramatsu. Keiichi...

The study shows that the human peptide LL‑37 can block a bacterial toxin (LPS) from killing blood‑vessel cells in lab dishes and in mice, which helps protect against severe sepsis. However, this work is still early‑stage animal research and doesn’t give a clear way for everyday people to use the peptide safely or effectively.

Utility 1
pubmed Jun 21, 2011

A novel organotypic dento-epithelial culture model: effect of Fusobacterium nucleatum biofilm on B-defensin-2, -3, and LL-37 expression.

Gursoy. Ulvi K UK; Pöllänen. Marja M; Könönen. Eija E; Uitto. Veli-Jukka VJ

The study looked at how a mouth bacteria (Fusobacterium nucleatum) affects the production of natural antimicrobial proteins (hBD‑2, hBD‑3, and LL‑37) in a lab model of gum tissue. It found that the bacteria quickly boost hBD‑2 and hBD‑3, but only cause a weak and limited increase in LL‑37, mainly after longer exposure with one bacterial strain.

Utility 1
pubmed Dec 3, 2010

The human cathelicidin, LL-37, induces granzyme-mediated apoptosis in cytotoxic T lymphocytes.

Mader. Jamie S JS; Marcet-Palacios. Marcelo M; Hancock. Robert E W RE; Bleackley. R Chris RC

The study found that the human peptide LL‑37 can kill activated killer T‑cells (CD8+ cells) by triggering a type of cell death that involves enzymes called granzymes, while it doesn’t harm resting T‑cells. This suggests LL‑37 can suppress certain immune functions, which could be a concern if you’re trying to boost immunity.

Utility 1
pubmed Apr 22, 2011

Circulating LL-37 is a biomarker for eczema severity in children.

Leung. T F TF; Ching. K W KW; Kong. A P S AP; Wong. G W K GW; Chan. J C N JC; Hon. K L KL

The study found that children with eczema have about the same amount of the immune peptide LL‑37 in their blood as healthy kids, but the amount goes up a bit as eczema gets worse. The link between LL‑37 levels and how bad the eczema is is weak, and it doesn’t relate to skin moisture or water loss.

Utility 1
pubmed 2011

Interdigitated electrodes based on impedance biosensor for sensing peptide LL-37.

Lee. Jia-Yi JY; Wang. Chung-Yih CY; Huang. Chi-Fang CF; Cheng. An-Ting AT

Scientists made a cheap electronic sensor that can spot the immune peptide LL‑37 in urine, which rises when you have a urinary tract infection. The device uses special electrodes and an antibody to detect LL‑37 down to about 50 µg per milliliter.

Utility 1
pubmed Aug 30, 2011

Mycobacterium abscessus activates the NLRP3 inflammasome via Dectin-1-Syk and p62/SQSTM1.

Lee. Hye-Mi HM; Yuk. Jae-Min JM; Kim. Ki-Hye KH; Jang. Jichan J; Kang. Gun G; Park. Jin Bong JB; Son...

The study shows that a type of bacteria (Mycobacterium abscessus) triggers a specific immune alarm system (the NLRP3 inflammasome) in human immune cells, and this process involves the antimicrobial peptide LL‑37 and several signaling proteins. While it explains how the body fights this infection, it doesn’t give direct tips or dosages for using LL‑37 or related compounds to boost health.

Utility 1
pubmed Sep 24, 2012

Clostridium difficile clinical isolates exhibit variable susceptibility and proteome alterations upon exposure to mammalian cationic antimicrobial peptides.

McQuade. Rebecca R; Roxas. Bryan B; Viswanathan. V K VK; Vedantam. Gayatri G

The study shows that different strains of the harmful gut bacterium C. difficile react differently to the human immune peptide LL‑37. Some epidemic strains are more resistant, and exposure to low levels of LL‑37 can make the bacteria even tougher by changing the proteins they make.

Utility 1
pubmed Feb 6, 2011

Human antimicrobial proteins in ear wax.

Schwaab. M M; Gurr. A A; Neumann. A A; Dazert. S S; Minovi. A A

Researchers found that ear wax contains a bunch of natural antimicrobial proteins, including LL‑37, which help keep the ear canal free from infections. Some of these proteins stick to cells in the wax, and together they act as a local defense system. This knowledge could lead to new ear‑specific treatments, but it doesn’t change how you take supplements or affect overall health directly.

Utility 1
pubmed Dec 1, 2013

Human β defensin-3 induces chemokines from monocytes and macrophages: diminished activity in cells from HIV-infected persons.

Petrov. Velizar V; Funderburg. Nicholas N; Weinberg. Aaron A; Sieg. Scott S

The study looked at how a few immune‑boosting peptides, including LL‑37, affect immune cells. It found that LL‑37 can trigger some signaling molecules, but it’s not as strong as another peptide (hBD‑3). People with HIV showed different immune responses, but the work doesn’t give clear guidance for everyday use.

Utility 1
pubmed Feb 11, 2012

Steroid requirements and immune associations with vitamin D are stronger in children than adults with asthma.

Goleva. Elena E; Searing. Daniel A DA; Jackson. Leisa P LP; Richers. Brittany N BN; Leung. Donald Y...

The study found that low vitamin D levels are linked to higher inhaled steroid use and weaker response to steroids in kids with asthma, but these links weren’t seen in adults. Vitamin D also seemed to lower allergy‑related IgE in children. LL‑37 levels in the blood rose with higher vitamin D in both age groups.

Utility 1
pubmed Jan 5, 2011

A novel p.S34N mutation of CAMP gene in patients with periodontal disease.

Türkoğlu. Oya O; Berdeli. Afig A; Emingil. Gülnur G; Atilla. Gül G

Researchers found a new genetic change (p.S34N) in the CAMP gene that makes the immune peptide LL‑37 slightly different, and this change is much more common in people with a severe, fast‑progressing gum disease called generalized aggressive periodontitis, but not in regular chronic gum disease or healthy people.

Utility 1
pubmed Feb 28, 2011

Differential changes in expression of intestinal antimicrobial peptide genes during Ascaris lumbricoides infection in Zambian adults do not respond to helminth eradication.

Kapulu. Melissa C MC; Simuyandi. Michelo M; Sianongo. Sandie S; Mutale. Mubanga M; Katubulushi. Max...

In people with Ascaris worm infections, the gut’s natural antibiotic protein LL‑37 (and a few others) is lower than in healthy folks, and this doesn’t bounce back even after the worms are cleared. The infection also shifts immune signals toward a Th1‑type response, which could affect how the body fights other germs and how oral vaccines work.

Utility 1
pubmed Apr 5, 2011

Susceptibility of clinical Staphylococcus aureus isolates to innate defense antimicrobial peptides.

Rieg. Siegbert S; Kaasch. Achim J AJ; Wehrle. Julian J; Hofmann. Silke C SC; Szymaniak-Vits. Magdale...

The study looked at how the natural antimicrobial peptide LL‑37 (and a couple of others) kills Staphylococcus aureus bacteria taken from sick patients versus harmless carriers. It found that LL‑37 works about the same on all the bacteria, with no big differences in how much is needed to stop growth.